Home > High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
| Title | High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Yoshihara, Kosuke, Tsunoda Tatsuhiko, Shigemizu Daichi, Fujiwara Hiroyuki, Hatae Masayuki, Fujiwara Hisaya, Masuzaki Hideaki, Katabuchi Hidetaka, Kawakami Yosuke, Okamoto Aikou, Nogawa Takayoshi, Matsumura Noriomi, Udagawa Yasuhiro, Saito Tsuyoshi, Itamochi Hiroaki, Takano Masashi, Miyagi Etsuko, Sudo Tamotsu, Ushijima Kimio, Iwase Haruko, Seki Hiroyuki, Terao Yasuhisa, Enomoto Takayuki, Mikami Mikio, Akazawa Kohei, Moriya Takuya, Tajima Atsushi, Inoue Ituro, and Tanaka Kenichi |
| Journal | Clinical Cancer Research |
| Date Published | January 12 |
| URL | http://clincancerres.aacrjournals.org/content/18/5/1374.short |
| Notes | Technology: Whole Human Genome Oligo Microarray (Agilent), Affymetrix® HG-U133Plus2.0, Whole Human Genome Oligo Microarray (Agilent), Affymetrix® (HG-U133A, HG-U133Plus2.0, and HT-HG-U133A), Genome-Wide Human SNP Array 6.0 (Affymetrix®) |